 |
市場調查報告書
商品編碼
1632061
恆電位儀：全球市場佔有率分析、產業趨勢/統計、成長預測（2025-2030）Global Potentiostat - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) |
||||||
價格
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
簡介目錄
預計全球恆電位儀市場在預測期內的複合年成長率為 2.7%。
主要亮點
- 減少前置作業時間、樣品使用量、測試成本以及與各種技術相關的限制的願望導致了技術創新和恆電位儀技術的創建。這些篩檢的篩檢採用預計將在媒介中增加，並且它為小型實驗室提供了擴大其服務範圍並與行業中較大的市場參與者競爭的機會。
- 2021 年 2 月，生物技術巨頭 Biocon 旗下子公司 Biocon Biologics 宣布，作為癌症獲取合作夥伴關係的一部分，計劃在非洲和亞洲 30 多個國家擴大救生癌症生物學名藥的使用範圍。 CHAI) 達成協議。這種合作可能會創造市場成長的機會。
- 隨著恆電位儀產品的使用量不斷增加，許多研究人員正在其製造過程中進行研究，許多研究人員正在使產品對客戶更有用。例如，2022 年6 月，一項題為「基於ESP32 微控制器的用於循環伏安分析的智慧型手機控制的低成本恆電位儀設計」的研究發現，基於電化學的分析具有我認為的簡單、彈性和低維護的優點。恆電位儀是進行電化學實驗和分析的基本儀器，特別是出於教育目的，開發低成本恆電位儀以允許中小型教育單位建立多功能迷你實驗室是必要的。此外，為了吸引大量技術採用者，必須開發小型攜帶式設備。我們創建了 eSTAT，這是一種使用 ESP32 微控制器的低成本、智慧型手機控制的恆電位儀系統。為了評估 eSTAT 的性能，使用循環伏安法 (CV) 測量來評估系統的準確性和容錯接受度。基於 ESP32 微控制器的智慧型手機控制低成本恆電位儀設計，用於循環伏安分析。
- COVID-19 大流行對全球各行業的供應鏈造成了嚴重破壞，導致世界各地許多公司暫停或減少業務以對抗病毒的傳播。疫情影響了無源電子元件業務，導致整個供應鏈的營運水準下降，特別是在元件和原料層面。這表示某些地區和國家的銷售額出現下降。
- 近期鎳、鐵、鉬等原物料價格大幅波動。受疫情影響，全球貴金屬市場供應鏈問題進一步負面影響，進一步影響市場價格。根據世界銀行的數據，2021年2月鎳價為每噸18,584.38美元，2020年12月鎳價為每噸16,823.04美元。原料成本上漲阻礙了生產並增加了營運成本。
恆電位儀市場趨勢
製藥業的應用是推動市場的因素之一
- 鑑於藥品使用和誤用的增加，藥品分析是一個重要的主題，涉及原料、配方和生物樣本中活性成分的鑑定和評估。進行雜質、分解產物、輔料、含量均勻度、溶離度、穩定性測試等測定。引用了許多應用，包括藥物品管、治療藥物監測、藥物動力學和臨床研究。
- 2022年3月，發表了題為「A Wireless Implantable Potentiostat for 可程式設計 Electrochemical Drug Delivery」的研究論文。研究人員提出了超音波驅動的植入式恆電位儀，具有雙向通訊，用於可程式設計電化學控制藥物傳輸。該系統由獨特的藥物傳輸模組、載藥電響應奈米顆粒和用於無線電源和資料的壓電換能器、180nm CMOS 積體電路和180nm CMOS 積體電路組成。該晶片包括一個可編程寬範圍恆電位儀，可產生高達 1.5V 的電位並測量高達 100A 的電流，以及一個 125kbps資料發送器。該藥物輸送系統已被證明可以無線供電並控制螢光素的釋放。
- FDA 藥物評估與研究中心 (CDER) 2021 年核准了50 種新藥和生物製藥。在核准的50個新藥和生物製藥中，有33個是小分子藥物，17個是單株抗體或其他大分子藥物。然而，近年來生物製藥的核准穩步增加。這些新興國家的發展預計將對市場產生正面影響。
- 多家公司正在合作開發新藥和治療方法，我們相信這將是開發市場的絕佳機會。例如，2022年4月，Astellas來製藥和東京大學開始了第二階段的合作研究，共同發現新的療法和醫療解決方案。Astellas來聯盟加速計畫是此次合作的名稱 (AAAP)。第一階段從2020年9月至2022年3月，AAAP為大學生命科學研究與教育研究所與東京大學創新中心的合作奠定了基礎。
- 此外，2021 年 11 月，牛津大學和巴西衛生署宣布了一項聯合舉措，將在巴西建立全球健康、合約和臨床研究單位。該部門開發新藥和疫苗，以推進正在進行的人類健康研究。我們還將提供感染疾病、臨床開發和疫苗學方面的碩士和博士生以及課程，並將重點培養新一代合約研究人員和臨床研究人員。
美洲佔主要市場佔有率
- 美國食品藥物管理局(FDA) 監管美國的藥品生產。 FDA 透過密切監控藥品製造商遵守現行良好生產規範 (CGMP) 法規的情況來確保藥品品質。藥品 CGMP 法規對用於製造、加工和包裝藥品的方法、設備和控制設定了最低要求。這些法規確保產品使用安全，並含有適合其功效和功效的成分。這些法規為應用程式的處理、內容和評估制定了指導方針，並規範了產品的設計、製造、製造和測試。這推動了市場。
- 可攜式恆電位儀是一種緊湊的攜帶式電池供電設備。它們的性能通常不如桌上型電腦型號，而且它們的用途往往受到限制。手持式恆電位儀特別適合現場測試，其中快速定量結果比完整的電化學研究更重要。
- 當地公司開發新產品或將新技術融入現有產品以滿足客戶需求。例如，總部位於美國的 Pine Research Instrumentation 提供 WaveNow 無線恆電位儀/恆定電流儀，這是一種可用於多種應用的多功能系統。它只比智慧型手機大一點，但堅固耐用，並且能夠執行所有傳統的電化學過程。 WaveNow 的電流解析度為 100 nA 至 100 mA，電壓範圍為 +/-4 V。 WaveNow 供教育環境、研究和工業實驗室的客戶使用。
- 2021 年 2 月，科學家開發了一種郵票大小的晶片，使 COVID-19 測試變得更加容易，並在智慧型手機上在 55 分鐘內提供觀察。美國萊斯大學的研究人員開發了一種微流體晶片，可以分析透過常規手指刺破收集的血清中SARS-CoV-2 核衣殼(N) 蛋白的濃度，該蛋白是COVID-19 的生物標記。透過將血清稀釋五倍，微晶片能夠在 25 分鐘內辨識出濃度較低的 N 蛋白（每毫升 10 皮克）。當Google Pixel 2行動電話與插入式恆電位儀結合使用時，血清濃度低至 230 皮克即可獲得陽性診斷。本設備可調節電壓並檢測產生的電流。
- 由於工作電極接地，因此對雜訊不敏感，電位和電流記錄器輸出均指向地，從而可以測量極小的電流，並且可以採用不同的基本恆電位儀設計。諸如此類的優勢為本地參與者創造了透過各種測試應用程式擴展業務的機會。
恆電位儀產業概況
全球恆電位儀市場分散。為了滿足保險業不斷變化的需求，參與者傾向於投資其產品的創新。此外，參與者正在採取夥伴關係、合併和收購等策略活動來擴大其影響力。近期市場發展趨勢如下：
- 2021 年 6 月 - 繼 VSP-3e 和 VMP-3e 取得成功之後，SP-50e 和 SP-150e 是 BioLogic Essential 系列恆電位儀「e」（改良型）系列的最新成員。 SP-150e 是成熟的 SP-150 的升級版本。與之前的型號相比，進行了多項改進。能夠為恆電位儀增加第二個通道是 SP-150e 的重要功能。此小型多通道雙恆定電位器增加了第二個通道，使得此電化學工作站特別適合能源應用。添加第二個通道擴大了用戶可用的應用範圍，特別是在電池測試和一般電化學方面。
- 2021 年 5 月 - Admiral Instruments 宣布與 Quantum Design 建立新的合作關係。他們的目標是讓世界各地的每個人都能使用下一代電化學設備，Quantum Design 很高興能夠支持義大利的這項努力。雖然傳統的恆電位儀非常昂貴且難以操作，但此次合作推出了 Squidstat 恆電位儀，它將強大的技術融入較小的佔地面積中，並提供市場領先的價格。此外，這個應用程式提供了一個非常基本的使用者介面。 Admiral 實現了這一切，同時保持了此類精密設備所需的研究級品質。
其他好處：
- Excel 格式的市場預測 (ME) 表
- 3 個月的分析師支持
目錄
第1章簡介
- 研究假設和市場定義
- 調查範圍
第2章調查方法
第3章執行摘要
第4章市場洞察
- 市場概況
- 產業吸引力－波特五力分析
- 新進入者的威脅
- 買方議價能力
- 供應商的議價能力
- 替代品的威脅
- 競爭公司之間的敵對關係
第5章市場動態
- 市場促進因素
- 市場挑戰
- 產業價值鏈分析（生態系統、通路、相關人員分析）
- COVID-19 對市場的影響
- 技術簡介
第6章 市場細分
- 按最終用戶使用情況
- 藥品
- 環境
- 食品檢驗
- 水質測試
- 其他
- 按地區
- 北美洲（北美洲、拉丁美洲）
- 歐洲、中東和非洲 (EMEA)
- 亞太地區
第7章 競爭格局
- 公司簡介
- Metrohm AG
- AMETEK Inc.
- BioLogic Sciences Instruments SA
- Danaher Corp.
- Gamry Instruments
- Harvard Bioscience Inc.
- Ivium Technologies BV
- Metrohm AG
第8章小型恆電位儀應用的研究論文引用
第9章 市場未來展望
簡介目錄
Product Code: 90983
The Global Potentiostat Market is expected to register a CAGR of 2.7% during the forecast period.
Key Highlights
- The desire to reduce lead time, sample usage, testing costs, and limitations associated with various technologies has resulted in technological innovation and the creation of potentiostat technologies. Because these technologies offer higher sensitivity, accuracy in results, reliability, multi-contaminant and non-targeted screening with low turnaround time, and other benefits, wide-scale adoption of these technologies provides an opportunity for medium- and small-scale laboratories to expand their service offerings and compete with large market players in the industry.
- In February 2021, Biocon Biologics, an arm of biotechnology major Biocon, announced that it had signed a pact with the Clinton Health Access Initiative (CHAI) to expand access to life-saving cancer biosimilars in over 30 countries in Africa & Asia as a part of the Cancer Access Partnership. Collaborations like this will create an opportunity for the market to grow.
- With the increase in the usage of potentiostat products lot of researchers are in the process of making it, and many researchers are making the product more useful to the customer. For instance, in June 2022, the research titled" Design of smartphone-controlled low-cost potentiostat for cyclic voltammetry analysis based on ESP32 microcontroller" states that electrochemical-based analysis has the advantages of simplicity, resilience, and low maintenance. A low-cost potentiostat, a basic piece of equipment for conducting electrochemistry experiments and analysis, is required to enable small-medium educational units to construct a multipurpose mini-laboratory, especially for educational purposes. Furthermore, developing portable and small devices may be required to attract many technology adopters. The ESP32 microcontroller was used to create eSTAT, a low-cost, smartphone-controlled potentiostat system. The accuracy and error tolerance of the system was assessed using Cyclic Voltammetry (CV) measurements, which were used to evaluate eSTAT's performance. Design of smartphone-controlled low-cost potentiostat for cyclic voltammetry analysis based on ESP32 microcontroller.
- The COVID-19 pandemic has led to enormous disruptions in supply chains across industries globally, due to which many businesses worldwide halted or reduced operations to help combat the spread of the virus. The pandemic has impacted the passive electronic components business, resulting in lower operation levels across the supply chain, particularly at the component and raw material levels. This indicates a drop in sales across several regions and countries.
- The prices of raw materials such as nickel, iron, molybdenum, etc., have recently seen significant changes. With the influence of the pandemic, the global precious metal market is further witnessing adverse effects of supply chain issues, which are further impacting the prices in the market. According to the World Bank, the nickel price stood at USD 18,584.38 in February 2021, which was USD 16,823.04 per metric ton in December 2020. The increase in the raw material cost will hamper production and increase the operational cost.
Potentiostat Market Trends
Applications in Pharmaceutical Industry is One of the Factor Driving the Market
- Pharmaceutical analysis is a significant subject connected to active component identification and evaluation in raw materials, pharmaceutical formulations, and biological samples in the current context of rising drug use and misuse. Impurities, degradation products, and excipients are determined, as well as content uniformity, dissolution, and stability tests. Medication quality control, therapeutic drug monitoring, pharmacokinetics, and clinical investigations are a few of the many cited uses.
- In March 2022, the research paper titled" A Wireless Implantable Potentiostat for Programmable Electrochemical Drug Delivery" States that Targeted, tailored, and on-demand therapies with minimal side effects are possible using implantable drug delivery devices. The researchers present an ultra-sonically powered implantable potentiostat with bidirectional communication for programmable electrochemically controlled drug delivery. A unique drug delivery module incorporating drug-loaded electro-responsive nanoparticles and piezoelectric transducers for wireless power and data, a 180 nm CMOS integrated circuit, and a 180 nm CMOS integrated circuit make up the system. A programmable wide-range potentiostat capable of producing potentials up to 1.5 V and measuring currents up to 100 A and a 125 kbps data transmitter is included in the chip. The medication delivery system is demonstrated using wirelessly powered and regulated fluorescein release.
- The FDA's Center for Drug Evaluation and Research (CDER) approved 50 new drugs and biological products in 2021. Of the 50 approved new drugs and biological products, 33 were small molecule drugs, and 17 were monoclonal antibodies and other big molecule drugs. However, biologic approvals have been increasing steadily over the past few years. Such developments will positively impact the market.
- Several firms are collaborating in developing new drugs, therapies, and many more, which will significantly create an opportunity for the market to grow. For Instance, in April 2022, Astellas Pharma and the University of Tokyo launched the second phase of their collaboration to discover novel therapeutics and medical solutions together. The Astellas Alliance Acceleration Program is the name of the collaboration (AAAP). AAAP established a foundation for the collaboration at the university's Institute for Life Science Research and Education and the University of Tokyo Center of Innovation during the initial phase, which lasted from September 2020 to March 2022.
- Furthermore, In November 2021, The University of Oxford and the Brazilian Ministry of Health announced a joint initiative to set up global health and contract and clinical research unit in Brazil. It will develop new drugs and vaccines to drive ongoing human health research. It will also focus on training a new generation of contract and clinical researchers by offering Masters and Ph.D. studentships and courses in infectious diseases, clinical development, and vaccinology.
Americas to Hold the Major Market Share
- The US Food and Drug Administration (FDA) regulates the manufacturing of drugs in the United States. It ensures the quality of drug products by carefully monitoring drug manufacturers' compliance with its Current Good Manufacturing Practice (CGMP) regulations. The CGMP regulations for drugs have set the minimum requirements for the methods, facilities, and controls used in drug manufacturing, processing, and packaging. These regulations ensure that a product is safe for use and includes the ingredients according to the claims. These regulations lay down guidelines for processing, content, and evaluation of applications and regulating products' design, production, manufacturing, and testing. This will drive the market.
- Portable potentiostats are compact, battery-powered instruments that can be carried around. They are often less powerful than desktop models and are more likely to be limited to a single purpose. Handheld potentiostats are ideal for testing in the field, especially where a quick quantitative result is more critical than a complete electrochemical study.
- The regional companies are developing new products or incorporating new techniques into existing products to meet customers' demands. For example, Pine Research Instrumentation, Inc., a United States-based company, provides a WaveNow Wireless potentiostat/galvanostat, a versatile system that can be used in various applications. Even though it is just larger than a smartphone, it is highly strong, sturdy, and capable of performing all traditional electrochemical processes. WaveNow has a current resolution of 100 nA to 100 mA and a voltage range of +/- 4 V. WaveNow is used in a teaching environment, research, and industrial laboratories by customers.
- In February 2021, scientists developed a stamp-sized chip that makes COVID-19 testing easier and provides findings in less than 55 minutes on a smartphone. Researchers from Rice University in the United States created a microfluidic chip that analyses the concentration of SARS-CoV-2 nucleocapsid (N) protein, a biomarker for COVID-19, in blood serum from a routine finger prick. By diluting the serum fivefold, the microchip could identify N protein at even lower quantities, at ten picograms per milliliter, in 25 minutes. It produced a positive diagnosis with a concentration as low as 230 picograms for the entire serum when paired with a Google Pixel 2 phone and a plug-in potentiostat. This device adjusts voltage and detects the resulting current.
- Due to the working electrode being grounded, it is noise-insensitive - the recorder outputs of both potential and current refer to ground, extreme small currents can be measured, and different basic potentiostat designs can be employed. Benefits like these will create an opportunity for the local players to expand their business in different testing applications.
Potentiostat Industry Overview
The Global Potentiostat Market is fragmented. Players tend to invest in innovating their product offerings to cater to the insurance industry's changing demands. Moreover, players adopt strategic activities like partnerships, mergers, and acquisitions to expand their presence. Some of the recent developments in the market are:
- June 2021 - Following the success of the VSP-3e and VMP-3e, the SP-50e and SP-150e are the latest additions to BioLogic's Essential line's "e" (improved) series of potentiostats. The SP-150e is an upgraded, updated version of the tried-and-true SP-150. It has several improvements over its predecessor. The ability to add a second channel to the potentiostat is a crucial feature of the SP-150e. Including a second channel to this tiny, multichannel bipotentiostat makes this electrochemical workstation particularly well suited to energy applications. The addition of a second channel expands the range of applications available to users, particularly in battery testing and general electrochemistry.
- May 2021 - Admiral Instruments has announced a new cooperation with Quantum Design. Their purpose is to make the next generation of electrochemistry equipment accessible to everyone worldwide, and quantum design is excited to assist them in this endeavor in Italy. Traditional potentiostats are notoriously expensive and difficult to operate; however, in this collaboration, the company employs Squidstat potentiostats, which pack strong technology into a small footprint at a market-leading price. The app also provides a delightfully basic user interface. Admiral accomplishes all this while maintaining the research-grade quality required of precision instruments in this class.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET INSIGHTS
- 4.1 Market Overview
- 4.2 Industry Attractiveness - Porter's Five Forces Analysis
- 4.2.1 Threat of New Entrants
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Bargaining Power of Suppliers
- 4.2.4 Threat of Substitutes
- 4.2.5 Intensity of Competitive Rivalry
5 MARKET DYNAMICS
- 5.1 Market Drivers
- 5.2 Market Challenges
- 5.3 Industry Value Chain Analysis (Ecosystem, Distribution Channel, and Stakeholder Analysis)
- 5.4 Impact of COVID-19 on the Market
- 5.5 Technological Snapshot
6 MARKET SEGMENTATION
- 6.1 By End-User Application
- 6.1.1 Pharmaceutical
- 6.1.2 Environmental
- 6.1.3 Food testing
- 6.1.4 Water Testing
- 6.1.5 Others
- 6.2 By Geography
- 6.2.1 Americas (North America, Latin America)
- 6.2.2 Europe, Middle East and Africa (EMEA)
- 6.2.3 Asia Pacific
7 COMPETITIVE LANDSCAPE
- 7.1 Company Profiles
- 7.1.1 Metrohm AG
- 7.1.2 AMETEK Inc.
- 7.1.3 BioLogic Sciences Instruments SA
- 7.1.4 Danaher Corp.
- 7.1.5 Gamry Instruments
- 7.1.6 Harvard Bioscience Inc.
- 7.1.7 Ivium Technologies BV
- 7.1.8 Metrohm AG
